Linda C. Andersson

Reproducing human and cross-species drug toxicities using a Liver-Chip

Kyung‐Jin Jang, Monicah A. Otieno, Janey Ronxhi et al. · Science Translational Medicine · 2019 · 474 citations

Pharmacy, Bioengineering, Toxicology +17

Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid

Alison J. Foster, Bhavik Chouhan, Sophie Regan et al. · Archives of Toxicology · 2019 · 113 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicity

Catherine C. Bell, Bhavik Chouhan, Linda C. Andersson et al. · Archives of Toxicology · 2020 · 57 citations · Full text

Veterinary Medicine, Pharmacology, Toxicology +17

Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines

Alexander Kvist, Kajsa P. Kanebratt, Anna Walentinsson et al. · Biochemical Pharmacology · 2018 · 56 citations

Medicine, Biochemistry, Pharmacology +16

Multiple Compound-Related Adverse Properties Contribute to Liver Injury Caused by Endothelin Receptor Antagonists

J. Gerry Kenna, Simone H. Stahl, Julie Eakins et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 47 citations

Pharmacy, Pharmacology, Toxicology +17